|
Over the past
15 years, the international medical plastics market, the average annual growth
rate of 15% to 18% in a variety of medical device market growth rate in the top.
The production of medical plastic products in China began in the last century,
70's, the earliest medical plastic products of PVC (PVC) infusion bag system,
which replaced the transport inconvenience, easily broken glass infusion
bottles. At present, medical plastic products has developed into a major export
of China's medical device products. However, due to cut-throat competition,
research and development lags behind many other reasons, in recent years, some
of the advantages of domestic medical plastic products, gradually reducing the
low-end is still the main export products, while the market demand for larger,
more expensive intervention catheters, kidney dialysis machines and other
high-end product development and production, should be strengthened.
Disposable
syringes industry advantage is no longer
The 20th
century, 80 years, domestic companies abroad imitation PVC disposable syringes
to be successful. As the production process of disposable syringes is relatively
simple and required little capital, technology content is low and easy to put
into production and so on, 90 years, thousands of businesses across the country
have launched projects disposable syringes, so that the rapid development of our
country to become the world's largest producer of disposable syringes is and
exporting country, while the disposable syringes are rapidly becoming the
largest domestic production of medical equipment products.
However, after
the market Ebb Tide, currently only the remaining 300 companies still producing
disposable syringes. Concern that the National disposable syringes on the total
capacity of up to 10 billion, but the actual annual output of only 30 billion to
4 billion, of which a large number of products exported to the international
market. Last year, China exported an average price of disposable syringes only
each 0.18 ~ 0.22 yuan. This price is close to cost price, export enterprises can
only earn that export tax rebates. This is the disposable syringes enterprises
in the international market, the consequences of vicious competition. Not only
that, due to the large number of China's export of disposable syringes, since
last year, Russia, Ukraine, Brazil, India and other countries on China's exports
disposable syringes filed anti-dumping lawsuits. These countries are China's
major export markets disposable syringes. Should the guilty in these countries,
they will charge 30% of China's disposable syringes and 50% of the 'punitive
tariffs', which will lead to changes in these countries from the importers to
import European manufacturers of similar products.
At present,
foreign countries need most is auto-disable syringes, prefilled syringe and
syringe needle-free syringes and other advanced products, in this respect, China
and the developed countries are fairly far behind.
Strengthen
the R & D and production of medical catheters
Medical
catheter (tube) products after China's second largest exporter of disposable
syringes medical plastic products. It is estimated that the national medical
plastic tube output of 2 billion or so, a number of catheter Plastic products
production and export in the international market leader, including the oxygen
tube, suction tube, gastric intubation, dialysis, drainage tubes, feeding
(liquid food) Tube, J-type catheter, negative pressure drainage tubes and other
medical catheters. However, the added value of these products is not high,
mostly Class Low-Value Consumable catheter (this is similar to the situation of
China's disposable syringes). In China, the implementation of more than ten
million new cases each year of cardiovascular stent implantation, making such
operations must be used to expand airbags and cardiovascular intervention
plastic catheter, but this high-grade catheter products in China has less
production, but a large number of imports from the United States - That is why
in the domestic hospital for a cardiovascular stent implantation surgery will
take several million yuan reasons. Import catheter and stent is too expensive,
ordinary working-class unbearable.
To be made
to improve the quality of kidney dialysis machines
At present,
about one million people worldwide have three people in uremic patients, they
need to have regular kidney dialysis, so hollow plastic fiber kidney dialysis
machine needs a huge number. However, the hollow plastic fiber kidney dialysis
machine market fundamentals for the United States, Germany, Sweden and Japan and
other developed countries monopolize. China hospital kidney dialysis machine 90%
of imported products. At present, the domestic hollow plastic fiber kidney
dialysis machine, not only in quality than similar products in developed
countries, production is running out. Many domestic hospitals for fear of
domestic hollow plastic fibers, but the quality of kidney dialysis machines can
not easily be purchased off of. In addition, while the demand from the market
point of view, development and production of domestically produced high-quality
plastic hollow fiber kidney dialysis machine has good prospects, but
unfortunately, our country has in the production of specialty plastic dialysis
hollow fibers have not yet made significant technological breakthrough, most
dependent on imports.
Urgent need
for replacement of artificial heart-lung machine
At present,
the foreign hospital for bypass surgery required an artificial heart-lung
machine (oxygenator) has plastic membrane oxygenator, but my hospital is still
using the backward Bubble oxygenator. Western medical researchers believe that
the plastic membrane oxygenator in the future is bound to replace the
traditional bubble-type oxygenator, as the former effect on plasma components
smaller. It is predicted that due to a number of countries like China are still
the same should be gradually to replace the bubble-type oxygenator, therefore,
plastic membrane oxygenator will be the next 10 years, best-selling products on
the international market.
In addition to
these products, domestic and overseas markets for much-needed artificial heart
valves, artificial blood vessels, artificial joints and other orthopedic
implantable medical devices such as high-end production of plastic products,
China is still in its infancy, both in product quality, quantity or variety of
both unable to compete with similar products in developed countries.
Development
of high-grade raw materials is a priority
Medical
plastic raw materials from the production and consumption can judge a country's
medical plastic products industry, degree of development. Currently,
manufacturers of medical plastic products in developed countries there are more
than 90 kinds of raw materials, including silicone rubber, polyurethane,
polyethylene terephthalate, polyamide, polyacrylonitrile, polyolefin,
polycarbonate, polyether, poly sulfone, polyacrylate, etc.. It was reported that
in 2008, China for the production of PVC medical plastic products as high as 5
million tons of raw materials, such polymer materials used in manufacture of
low-grade medical products, and our polycarbonate, polyethylene terephthalate ,
polyether, polysulfone polymer such as relatively high prices of medical
consumption of plastic raw materials, much lower than Europe and the United
States, Japan and other developed countries. This shows that our medical plastic
products in the technical level there is a big gap with the developed countries.
Developed high-grade medical plastic products used in the consumption of new
materials, polymer cent of their production of medical polymer materials, 40%,
while the proportion of China's less than 10%.
In view of
this, our medical plastic products to break the high-volume, low-return of the
existing structure, the only way out is to increase investment to develop
much-needed domestic and foreign markets high-end medical plastic products.
Otherwise, as in Vietnam, Thailand and Malaysia and other Southeast Asian newly
industrialized countries of the medical plastic products processing industry,
the rapid rise in the future is bound to low-end of our disposable syringes and
other medical plastic products pose a threat to the export. Rely solely on
export large volumes of low-grade medical plastic products to swap the old road
will be increasingly difficult to walk, my company has only determined to take
the 'technological innovation' the road to open up a new world.
Retrieved
from
http://www.articlesbase.com/organizational-articles/medical-plastic-products-industry-an-urgent-need-to-strengthen-technical-innovation-2072123.html
(ArticlesBase SC #2072123).
|
|
